Your browser doesn't support javascript.
loading
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.
Zátopková, Martina; Sevcíková, Tereza; Fanfani, Viola; Chyra, Zuzana; Ríhová, Lucie; Bezdeková, Renata; Zihala, David; Growková, Katerina; Filipová, Jana; Cerná, Lucie; Broskevicova, Lucie; Kryukov, Fedor; Minarík, Jirí; Smejkalová, Jana; Maisnar, Vladimír; Harvanová, Lubica; Pour, Ludek; Jungova, Alexandra; Popková, Tereza; Bago, Juli Rodriguez; Anilkumar Sithara, Anjana; Hrdinka, Matous; Jelínek, Tomás; Simícek, Michal; Stracquadanio, Giovanni; Hájek, Roman.
Afiliação
  • Zátopková M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Sevcíková T; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Fanfani V; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic.
  • Chyra Z; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Ríhová L; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Bezdeková R; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic.
  • Zihala D; Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh, United Kingdom.
  • Growková K; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Filipová J; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Cerná L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Broskevicova L; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Kryukov F; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Minarík J; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Smejkalová J; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Maisnar V; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic.
  • Harvanová L; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Pour L; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Jungova A; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic.
  • Popková T; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Bago JR; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Anilkumar Sithara A; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Hrdinka M; Clinical Development Department, Joint-stock Company BIOCAD, Saint Petersburg, Russia.
  • Jelínek T; Department of Hematooncology, University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
  • Simícek M; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Stracquadanio G; 4th Department of Medicine-Haematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Hájek R; Department of Hematology and Transfusiology, University Hospital Bratislava, Bratislava, Slovakia.
Blood Adv ; 6(2): 368-372, 2022 01 25.
Article em En | MEDLINE | ID: mdl-34500459
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: República Tcheca